Provided by Tiger Trade Technology Pte. Ltd.

Norway Government Pension Fund

1,282.849
+0.9120.07%
Number of Gainers:22
Number of Losers:30
Number of Flat:1
PE:- -
High:1,293.707
Open:1,284.681
Low:1,278.310
Close:1,281.937
Volume:3.49B
Turnover:55.32B
Market Cap:31.56T
Float Cap:20.73T

Loading ...

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 20

Longfor Group Holdings Stock Rallies 5.0% in Hong Kong

Dow Jones
·
Aug 20

Galaxy Entertainment Group (SEHK:27), What Is Behind The Fresh Attention?

Simply Wall St.
·
Aug 20

AH Share Premium Ranking Update: August 20 Market Close

Stock News
·
Aug 20

BOC Hong Kong, Alibaba's Ant International Join Hands for AI-Supported Financial Services

MT Newswires Live
·
Aug 20

CSPC Pharma Surges 15% as Moderna's mRNA Cancer Vaccine Hits Key Milestone

Stock News
·
Aug 20

Former Party Secretary and President of ABC's Jilin Branch Under Investigation

Deep News
·
Aug 20

Citi Lifts SBP GROUP Price Target to HK$10.8, Citing Strong H1 Beat

Stock News
·
Aug 20

JPMorgan Trims China Resources Beer Target to HK$28, Keeps Overweight Call

Stock News
·
Aug 20

Should MTR’s 2026 Profit Surge And Interim Dividend Require Action From MTR (SEHK:66) Investors?

Simply Wall St.
·
Aug 20

Is Longfor Group Holdings (SEHK:960) Still Below Fair Value Following Weak Profit Guidance?

Simply Wall St.
·
Aug 20

Finland's Arctic Blue Beverages Q2 Revenue Falls on Decline in Gin Sales

Reuters
·
Aug 20

Citi Adjusts China Res Beer Price Target Down to HK$34.23, Keeps Buy Rating

Stock News
·
Aug 20

Norway's Vistin Pharma Q2 Revenue Falls on Currency Impact

Reuters
·
Aug 20

CSPC Pharma (01093) Surges Over 12% After Interim Profit Jumps Nearly 1.4-Fold

Stock News
·
Aug 20

Austria's UNIQA H1 Premiums Rise on Property, Casualty Growth

Reuters
·
Aug 20

CSPC Pharmaceutical Hits 6-Month High on Profit, Dividend Surge

Reuters
·
Aug 20

Finland's Nanoform Q2 Ebitda Loss Narrows on Layoffs, Cost Cuts

Reuters
·
Aug 20

CSPC Pharmaceutical's Attributable Profit More Than Doubles in H1; Shares Jump 14%

MT Newswires Live
·
Aug 20

CSPC Pharma FY26 H1 Profit Attributable to Shareholders More than Doubled to RMB 6.09 Billion; Revenue Rises 40.1% to RMB 18.59 Billion

Reuters
·
Aug 20